Every 8-K that PACS Group, Inc. (PACS) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow PACS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full PACS filings page.
PACS Group, Inc. reported strong second quarter 2026 results, with revenue of $1.43 billion, up 9.1% year over year. Net income was $76.3 million, an increase of 49.8%, and diluted EPS was $0.47, up 51.6%. Adjusted EPS was $0.63, up 34.0%, Adjusted EBITDA was $166.8 million, up 24.6%, and Adjusted EBITDAR reached $261.5 million.
Same‑store skilled nursing revenue grew 5.8%, with occupancy rising to 90.6% from 89.1%. Overall occupancy was 90.4% versus an industry average of 79.5%, and skilled mix increased to 30.0%. Cash provided by operating activities was $371.8 million for the first half of 2026, and available liquidity was $756.6 million, including $164.5 million of cash and cash equivalents.
The company is expanding through the previously announced Eduro Healthcare transaction for 34 skilled nursing facilities totaling 3,633 beds, having closed on 20 Texas facilities as of August 1, 2026. PACS raised its 2026 guidance, lifting Adjusted EBITDA to $640–$660 million and revenue to $5.75–$5.85 billion, reflecting contributions from the closed Eduro Texas facilities.
PACS Group, Inc. reported the results of its 2026 Annual Meeting of Stockholders held on June 10, 2026. A total of 152,966,362 shares of common stock were represented online or by proxy, representing approximately 97.33% of shares outstanding as of the April 15, 2026 record date, indicating very high stockholder participation.
Stockholders elected Class II directors Evelyn Dilsaver and Mark Hancock to serve until the 2029 Annual Meeting. Dilsaver received 138,610,797 votes for and 7,339,538 votes withheld, while Hancock received 145,054,309 votes for and 896,026 votes withheld, with 7,016,027 broker non-votes for each nominee.
Stockholders also ratified the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026, with 152,909,016 votes for, 46,759 against, and 10,587 abstaining. In addition, they approved, on an advisory and non-binding basis, the compensation of the company’s named executive officers, with 131,950,911 votes for, 13,973,853 against, 25,571 abstentions, and 7,016,027 broker non-votes.
PACS Group reported a strong first quarter of 2026 with higher growth and profitability. Revenue reached $1.42 billion, up 11.2% from the prior year. Net income rose to $80.7 million, an increase of $52.3 million or 184.2% from $28.4 million, while basic earnings per share improved to $0.51 from $0.18.
Adjusted EBITDA was $170.4 million, up 74.6% from $97.6 million and included about $16.3 million of benefit from California’s Workforce & Quality Incentive Program. Cash provided by operating activities was $236.3 million, and available liquidity was $795.1 million as of March 31, 2026, including $248.0 million in cash and cash equivalents.
Operationally, skilled nursing occupancy was 90.8% compared to an industry average of 79%, and same-store skilled nursing revenue grew 8.0%. The company raised full-year 2026 Adjusted EBITDA guidance to $605–$625 million, about 22% growth over 2025 at the midpoint, and reaffirmed revenue guidance of $5.65–$5.75 billion. The board also approved a $250 million share repurchase authorization, adding another capital allocation option.
PACS Group, Inc. announced a planned finance leadership transition. The Board appointed Carey P. Hendrickson as Chief Financial Officer and principal financial officer effective April 27, 2026. Co‑founder and Executive Vice Chairman Mark Hancock will retire as an executive officer on June 30, 2026 but remain Vice Chairman of the Board.
Hendrickson joins from U.S. Physical Therapy after prior CFO roles at Capital Senior Living and Belo Corp. His offer includes a $475,000 base salary, a target annual bonus of $3,800,000, and restricted stock units valued at $2,000,000 that vest over three years. He will also be eligible under PACS’s Executive Severance Plan.
The company highlights Hancock’s role in growing PACS from two facilities in 2013 to 323 facilities across 17 states, serving more than 31,700 patients daily, and generating $5.29 billion of full‑year 2025 revenue, a 29.3% year‑over‑year increase. Two press releases detailing Hancock’s retirement and Hendrickson’s appointment are furnished as exhibits.
PACS Group, Inc. has appointed Patrick H. Conway, MD, MSc, to its Board of Directors as a Class III director, with a term running until the 2027 annual stockholders’ meeting. He will receive the standard non-employee director compensation and sign the company’s usual indemnification agreement.
Dr. Conway is CEO of Optum, the health services business of UnitedHealth Group, and a former senior leader at the Centers for Medicare and Medicaid Services, where he helped drive the shift toward value-based care. The company highlights his clinical background as a practicing pediatric hospitalist and his national recognition for healthcare leadership.
The filing also notes that PACS operates more than 320 post-acute care facilities across 17 states, serves over 31,700 patients daily, and reported full-year 2025 revenue of $5.29 billion, a 29.3% year-over-year increase, underscoring its scale and recent growth in the skilled nursing sector.
PACS Group, Inc. reported strong growth for 2025, with revenue of $5.29 billion, up 29.3% from the prior year, and net income of $191.5 million. Adjusted EBITDA reached $505.0 million and Adjusted EBITDAR was $883.9 million, reflecting higher scale and profitability.
Fourth-quarter 2025 revenue was $1.36 billion, up 12.4% year over year, with net income of $59.8 million and Adjusted EBITDA of $142.1 million. Cash from operating activities was $404.2 million, and cash and cash equivalents were $197.0 million as of December 31, 2025. For 2026, the company expects revenue of $5.65–$5.75 billion and Adjusted EBITDA of $555–$575 million, supported by a 323‑facility portfolio and continued expansion.
PACS Group, Inc. reported the results of its 2025 Annual Meeting of Stockholders held on December 19, 2025. A total of 149,241,113 shares, representing approximately 95.29% of the company’s common stock as of the November 10, 2025 record date, were represented online or by proxy, indicating very high shareholder participation.
Stockholders elected Class I directors Taylor Leavitt and Jacqueline Millard to serve until the 2028 annual meeting. They also ratified the appointment of Ernst & Young LLP as independent registered public accounting firm for the year ending December 31, 2025. In advisory votes, stockholders approved the company’s executive compensation and supported holding future say-on-pay votes every year, and the company plans to conduct these advisory votes annually unless the board later determines a different frequency is preferable.
PACS Group, Inc. reported that it entered into a Sixth Amendment to its Amended and Restated Credit Agreement with Truist Bank and its lenders on November 26, 2025. This amendment waives all previously identified defaults and events of default under the credit facility that had been disclosed in a forbearance agreement dated October 21, 2025.
The amendment also adjusts a key financial covenant so that the requirement to maintain at least $100 million of unrestricted cash and certain permitted investments applies only until the company delivers financial statements and a compliance certificate for the fiscal quarter ending June 30, 2026. On the same date, the company obtained a corresponding waiver of all previously identified events of default under its Third Consolidated Master Lease.
PACS Group, Inc. reported that it has released its financial results for the period ended September 30, 2024. The company furnished a press release as an exhibit to this current report, rather than formally filing the detailed results in the body of the report itself. This means the main financial and operating figures are contained in the accompanying press release referenced as Exhibit 99.1.
PACS Group, Inc. reported that its lenders, led by Truist Bank as administrative agent, extended their forbearance under the Credit Agreement through November 30, 2025. The landlords under the Company’s Omega Master Lease also agreed to forbear through the same date, providing temporary relief while discussions continue.
The Company also referenced its November 19, 2025 deadline with the NYSE to regain compliance with Section 802.01E by becoming current in its SEC reporting. The cautionary note highlights risks tied to the restatement process, the ongoing Audit Committee investigation, and the potential for an NYSE delisting determination.
PACS Group, Inc. filed a current report to let investors know it has released select unaudited preliminary operating metrics. The company states that these figures were announced in a press release dated September 11, 2025, which is included as Exhibit 99.1 to the report. The metrics are described as preliminary and unaudited, meaning they are early performance indicators rather than final results. The company also clarifies that this information is being furnished, not filed, so it is not automatically subject to certain Exchange Act liabilities or incorporated into other securities filings unless specifically referenced.
PACS Group, Inc. reports that the NYSE Listing Operations Committee has granted the company an additional trading period through November 19, 2025 to regain compliance with NYSE rule 802.01E on timely filing of annual and quarterly reports, with the situation reassessed on an ongoing basis. The company has not yet filed its Form 10-Q for the quarter ended September 30, 2024, its Form 10-K for the year ended December 31, 2024, or its Forms 10-Q for the quarters ended March 31, 2025 and June 30, 2025, due to an independent Audit Committee investigation. PACS Group previously said that its condensed combined/consolidated financial statements for the quarters ended March 31, 2024 and June 30, 2024 should no longer be relied upon and is working to restate these statements and complete the delayed reports. The NYSE will monitor the company’s progress as it seeks to return to full listing compliance.
PACS Group, Inc. reported that Chief Financial Officer Derick Apt resigned on September 2, 2025 after the board’s Audit Committee, following allegations he accepted a series of high-value items from individuals linked to entities that do business with the company, made interim findings that his receipt of those items violated company policies and its Code of Conduct. In a separation agreement, Apt provided a broad release of claims and reaffirmed non-solicitation, non-disparagement and confidentiality covenants, while the company agreed to accelerate vesting of 82,116 restricted stock units, with his remaining unvested units forfeited, and waived a one-year non-competition covenant. The company has launched a search for a permanent CFO and bolstered its finance and accounting resources. On September 3, 2025, co-founder and current Executive Vice Chairman Mark Hancock, who previously served as CFO from 2013 to 2024, was appointed interim Chief Financial Officer and will act as principal financial officer while continuing as a director.
PACS Group, Inc. disclosed that Peter (P.J.) Sanford, President of Providence Administrative Consulting Services, Inc., resigned as an employee and executive officer of the company effective August 15, 2025. The parties negotiated a separation agreement under which Mr. Sanford will execute a general release of claims and reaffirm his continuing obligations under certain restrictive covenants. The company agreed to subsidize 12 months of Mr. Sanford's COBRA premiums. The company will also enter a consulting agreement to keep Mr. Sanford available to provide services. The filing states the full separation and consulting agreements will be filed as exhibits to the company's next quarterly report.